Milestone Pharmaceuticals (MIST) Earnings Date & Reports

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

MIST is expected to report earnings to rise 15.79% to -21 cents per share on May 19

Milestone Pharmaceuticals MIST Stock Earnings Reports

Q1'25

Est.

$-0.22

Q4'24

Missed

by $0.03

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.05

The last earnings report on March 13 showed earnings per share of -18 cents, missing the estimate of -15 cents. With 2.54M shares outstanding, the current market capitalization sits at 42.85M.

View a ticker or compare two or three

Compare

MIST